We’re reader-supported and may be paid when you visit links to partner sites. We don’t compare all products in the market, but we’re working on it!
Ansell Limited is a medical instruments & supplies business based in Australia. Ansell shares (ANN) are listed on the Australian Securities Exchange (ASX) and all prices are in Australian Dollars. Ansell has a trailing 12-month revenue of around $2 billion. If you're looking to buy shares, check out the steps below.
Our top pick for
US stocks
Our top pick for
ETF investing
Our top pick for
Overall broker
| 52-week range | $32 - $43.3302 |
|---|---|
| 50-day moving average | $35.0125 |
| 200-day moving average | $39.0292 |
| Target price | $44.5 |
| PE ratio | 12.7024 |
| Dividend yield | $0.768 (2.39%) |
| Earnings per share (TTM) | $2.557 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Historical closes compared with the last close of A$31.82
| 1 week (2021-10-15) | -2.03% |
|---|---|
| 1 month (2021-09-22) | -9.19% |
| 3 months (2021-07-22) | -22.12% |
| 6 months (2021-04-22) | -18.03% |
| 1 year (2020-10-22) | -22.12% |
|---|---|
| 2 years (2019-10-22) | 14.38% |
| 3 years (2018-10-22) | 41.99% |
| 5 years (2016-10-21) | 42.82% |
Valuing Ansell stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Ansell's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Ansell's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 13x. In other words, Ansell shares trade at around 13x recent earnings.
That's relatively low compared to, say, the P/E ratio for the ASX over the 12 months to December 2019 (32.14). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Ansell's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $366 million (£0.0 million).
The EBITDA is a measure of a Ansell's overall financial performance and is widely used to measure a its profitability.
| Revenue TTM | $2 billion |
|---|---|
| Operating margin TTM | 16.28% |
| Gross profit TTM | $810 million |
| Return on assets TTM | 7.97% |
| Return on equity TTM | 16.78% |
| Profit margin | 12.17% |
| Book value | 12.185 |
| Market capitalisation | $4.1 billion |
TTM: trailing 12 months
Dividend payout ratio: 31.82% of net profits
Recently Ansell has paid out, on average, around 31.82% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 3.12% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Ansell shareholders could enjoy a 3.12% return on their shares, in the form of dividend payments. In Ansell's case, that would currently equate to about A$0.768 per share.
While Ansell's payout ratio might seem fairly standard, it's worth remembering that Ansell may be investing much of the rest of its net profits in future growth.
The latest dividend was paid out to all shareholders who bought their shares by 29 August 2021 (the "ex-dividend date").
Ansell's shares were split on a 1:5 basis on 14 April 2002. So if you had owned 5 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Ansell shares – just the quantity. However, indirectly, the new 400% higher share price could have impacted the market appetite for Ansell shares which in turn could have impacted Ansell's share price.
Over the last 12 months, Ansell's shares have ranged in value from as little as $32 up to $43.3302. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (AU average) beta is 1, while Ansell's is 0.4108. This would suggest that Ansell's shares are less volatile than average (for this exchange).
Ansell Limited designs, develops, and manufactures protection solutions in the Asia Pacific, Europe, the Middle East, Africa, Latin America, the Caribbean, and North America. It operates in two segments, Healthcare and Industrial. The Healthcare segment manufactures and markets solutions comprising surgical gloves, single use and examination gloves, and clean and sterile gloves and garments, as well as consumables used by hospitals, surgical centers, dental practices, veterinary clinics, first responders, laboratories, and life sciences and pharmaceutical companies. The Industrial segment manufactures and markets hand and chemical protective clothing solutions for a range of industrial applications, including automotive, chemical, metal fabrication, machinery and equipment, food, construction, mining, oil and gas, and first responders. The company was formerly known as Pacific Dunlop Limited and changed its name to Ansell Limited in 2002. Ansell Limited was founded in 1893 and is based in Richmond, Australia.
Steps to owning and managing ProShares Bitcoin Strategy ETF units.
Shares in the wealth management giant have been largely stable in the last 6 months.
Everything we know about the Judo Capital Holdings IPO, plus information on how to buy in.
Everything we know about the Alloggio Group IPO, plus information on how to buy in.
Everything we know about the Larvotto Resources IPO, plus information on how to buy in.
Everything we know about the Vulcan Steel IPO, plus information on how to buy in.
Everything we know about the Artrya IPO, plus information on how to buy in.
Everything we know about the 8 Au IPO, plus information on how to buy in.
Everything we know about the Radiopharm Theranostics IPO, plus information on how to buy in.
The online retailer’s shares have lost more than half their value in the last 12 months.
